Thermage, a manufacturer of medical devices for the treatment of wrinkles, set the terms for its IPO on Tuesday. The company plans to offer 6 million shares at a range of $11-$13. The deal has a proposed market cap of $305 million and is expected to price the week of November 6th. Merrill Lynch will lead the group of underwriters on the deal.
